Gene Polymorphisms of ADIPOQ +45T>G, UCP2 -866G>A, and FABP2 Ala54Thr on the Risk of Colorectal Cancer: A Matched Case-Control Study

PLoS ONE

Volumn 8, Issue 6, 2013, Pages

  Hu, Xiaoqin ^a   Yuan, Ping ^a   Yan, Jin ^b   Feng, Fei ^a   Li, Xiaoling ^a   Liu, Wenhui ^a   Yang, Yanfang ^a  

^a SICHUAN UNIVERSITY   (China)

^b SICHUAN CANCER HOSPITAL   (China)

Author keywords

[No Author keywords available]

Indexed keywords

ADIPONECTIN; FATTY ACID BINDING PROTEIN 2; UNCOUPLING PROTEIN 2; ADIPOQ PROTEIN, HUMAN; FABP2 PROTEIN, HUMAN; FATTY ACID BINDING PROTEIN; UCP2 PROTEIN, HUMAN;

ADIPOQ GENE; ADULT; AGED; ARTICLE; BLOOD SAMPLING; CANCER RISK; COLORECTAL CANCER; CONTROLLED STUDY; DIETARY INTAKE; ENVIRONMENTAL FACTOR; FABP2 GENE; FEMALE; GENE DOSAGE; GENE INTERACTION; GENETIC ASSOCIATION; GENETIC PREDISPOSITION; GENOTYPE; GENOTYPE ENVIRONMENT INTERACTION; HUMAN; INSULIN RESISTANCE; LIFESTYLE; MAJOR CLINICAL STUDY; MALE; MULTIFACTOR DIMENSIONALITY REDUCTION; RED MEAT; RISK ASSESSMENT; SINGLE NUCLEOTIDE POLYMORPHISM; UCP2 GENE; ADVERSE EFFECTS; CASE CONTROL STUDY; COLORECTAL NEOPLASMS; DIET; EPISTASIS; GENETICS; MIDDLE AGED; VERY ELDERLY; YOUNG ADULT;

ADIPONECTIN; ADULT; AGED; AGED, 80 AND OVER; CASE-CONTROL STUDIES; COLORECTAL NEOPLASMS; DIET; EPISTASIS, GENETIC; FATTY ACID-BINDING PROTEINS; FEMALE; GENE-ENVIRONMENT INTERACTION; GENETIC PREDISPOSITION TO DISEASE; HUMANS; LIFE STYLE; MALE; MIDDLE AGED; POLYMORPHISM, SINGLE NUCLEOTIDE; RED MEAT; UNCOUPLING PROTEIN 2; YOUNG ADULT;

EID: 84879523487     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0067275     Document Type: Article

References (63)

1. Ferlay J, Shin HR, Bray F, Forman D, Mathers C, et al. (2010) GLOBOCAN 2008 v1.2, Cancer Incidence and Mortality Worldwide: IARC CancerBase No. 10.Lyon, France: International Agency for Research on Cancer. Available: http://globocan.iarc.fr. Accessed 11 December 2012.
2. Center MM, Jemal A, Smith RA, Ward E (2009) Worldwide variations in colorectal cancer. CA Cancer J Clin 5: 366-378.
3. Zhao P, Zhang WQ (2011) Chinese tumor registration report in 2010. Beijing, China: Military medical science press.
4. Kotnis A, Sarin R, Mulherkar R, (2005) Genotype, phenotype and cancer: Role of low penetrance genes and environment in tumour susceptibility. J Biosci 30: 93-102.
5. Michael M (2007) Food, Nutrition, Physical Activity, and the Prevention of Cancer: a Global Perspective. World Cancer Research Fund & American Institute for Cancer Research, Washington, DC.
6. Gingras D, Béliveau R, (2011) Colorectal cancer prevention through dietary and lifestyle modifications. Cancer Microenviron 4: 133-139.
7. Basen-Engquist K, Chang M, (2011) Obesity and cancer risk: recent review and evidence. Curr Oncol Rep 13: 71-76.
8. Noto H, Tsujimoto T, Sasazuki T, Noda M, (2011) Significantly increased risk of cancer in patients with diabetes mellitus: a systematic review and meta-analysis. Endocr Pract 17: 616-628.
9. Zeyda M, Stulnig TM, (2009) Obesity, inflammation, and insulin resistance-a mini-review. Gerontology 55: 379-386.
10. Wilkin TJ, (2009) The accelerator hypothesis: a review of the evidence for insulin resistance as the basis for type I as well as type II diabetes.Int J Obes (Lond). 33: 716-726.
11. McKeown-Eyssen G, (1994) Epidemiology of colorectal cancer revisited: are serum triglycerides and/or plasma glucose associated with risk? Cancer Epidemiol Biomarkers Prev 3: 687-695.
12. Giovannucci E, (1995) Insulin and colon cancer. Cancer Causes Control 6: 164-179.
13. Consensus Development Conference on Insulin Resistance. American Diabetes Association. Diabetes Care 21: 310-314.
14. Harano Y, Koyama Y, (2001) Molecular mechanism of insulin resistance in hyperlipidemia. Nihon Rinsho 59: 726-731.
15. Djiogue S, Nwabo Kamdje AH, Vecchio L, Kipanyula MJ, Farahna M, et al. (2013) Insulin resistance and cancer: the role of insulin and IGFs. Endocr Relat Cancer 20: R1-R17.
16. Pollak M, (2008) Insulin and insulin-like growth factor signalling in neoplasia. Nature Reviews Cancer 8: 915-928.
17. Leng SL, Leeding KS, Gibson PR, Bach LA (2001) Insulin-like growth factor-II renders LIM 2405 human colon cancer cells resistant to butyrate-induced apoptosis: a potential mechanism for colon cancer cell survival in vivo. Carcinogenesis 22, 1625-1631.
18. D'Apolito M, Du X, Zong H, Catucci A, Maiuri L, et al. (2010) Urea-induced ROS generation causes insulin resistance in mice with chronic renal failure. J Clin Invest 120: 203-213.
19. Tuncman G, Hirosumi J, Solinas G, Chang L, Karin M, et al. (2006) Functional in vivo interactions between JNK1 and JNK2 isoforms in obesity and insulin resistance. Proc Natl Acad Sci USA 103: 10741-10746.
20. Cowey SL, Quast M, Belalcazar LM, Wei J, Deng X, et al. (2005) Abdominal obesity, insulin resistance, and colon carcinogenesis are increased in mutant mice lacking gastrin gene expression. Cancer 103: 2643-2653.
21. Limburg PJ, Stolzenberg-Solomon RZ, Vierkant RA, Roberts K, Sellers TA, et al. (2006) Insulin, glucose, insulin resistance, and incident colorectal cancer in male smokers. Clin Gastroenterol Hepatol 4: 1514-1521.
22. Ortiz AP, Thompson CL, Chak A, Berger NA, Li L, (2012) Insulin resistance, central obesity, and risk of colorectal adenomas. Cancer 118: 1774-1781.
23. Komninou D, Ayonote A, Richie JP Jr, Rigas B, (2003) Insulin resistance and its contribution to colon carcinogenesis. Exp Biol Med (Maywood) 228: 396-405.
24. Barnea M, Shamay A, Stark AH, Madar Z, (2006) A high-fat diet has a tissue-specific effect on adiponectin and related enzyme expression. Obesity (Silver Spring) 14: 2145-2153.
25. Zhong R, Liu L, Zou L, Sheng W, Zhu B, et al. (2013) Genetic variations in the TGFβ signaling pathway, smoking and risk of colorectal cancer in a Chinese population. Carcinogenesis 34: 936-942.
26. Liu L, Zhong R, Wei S, Yin JY, Xiang H, et al. (2011) Interactions between genetic variants in the adiponectin, adiponectin receptor 1 and environmental factors on the risk of colorectal cancer. PLoS One 6: e27301.
27. Liu L, Wu C, Wang Y, Zhong R, Wang F, et al. (2011) Association of candidate genetic variations with gastric cardia adenocarcinoma in Chinese population: a multiple interaction analysis. Carcinogenesis 32: 336-342.
28. Xita N, Georgiou I, Chatzikyriakidou A, Vounatsou M, Papassotiriou GP, et al. (2005) Effect of adiponectin gene polymorphisms on circulating adiponectin and insulin resistance indexes in women with polycystic ovary syndrome. Clin Chem 51: 416-423.
29. Heidari J, Akrami SM, Heshmat R, Amiri P, Fakhrzadeh H, et al. (2010) Association study of the-866G/A UCP2 gene promoter polymorphism with type 2 diabetes and obesity in a Tehran population: a case control study. Arch Iran Med 13: 384-390.
30. Georgopoulos A, Aras O, Noutsou M, Tsai MY, (2002) Unlike type 2 diabetes, type 1 does not interact with the codon 54 polymorphism of the fatty acid binding protein 2 gene. J Clin Endocrinol Metab 87: 3735-3739.
31. Andersson T, Alfredsson L, Källberg H, Zdravkovic S, Ahlbom A, (2005) Calculating measures of biological interaction. Eur J Epidemiol 20: 575-579.
32. Lou XY, Chen GB, Yan L, Ma JZ, Zhu J, et al. (2007) A generalized combinatorial approach for detecting gene-by-gene and gene-by-environment interactions with application to nicotine dependence. Am J Hum Genet 80: 1125-1137.
33. Hahn LW, Ritchie MD, Moore JH, (2003) Multifactor dimensionality reduction software for detecting gene-gene and gene-environment interactions. Bioinformatics 19: 376-382.
34. Li Y, Li X, Shi L, Yang M, Yang Y, et al. (2011) Association of adiponectin SNP+45 and SNP+276 with type 2 diabetes in Han Chinese populations: a meta-analysis of 26 case-control studies. PLoS One 6: e19686.
35. Chung HK, Chae JS, Hyun YJ, Paik JK, Kim JY, et al. (2009) Influence of adiponectin gene polymorphisms on adiponectin level and insulin resistance index in response to dietary intervention in overweight-obese patients with impaired fasting glucose or newly diagnosed type 2 diabetes. Diabetes Care 32: 552-558.
36. Melistas L, Mantzoros CS, Kontogianni M, Antonopoulou S, Ordovas JM, et al. (2009) Association of the +45T>G and +276G>T polymorphisms in the adiponectin gene with insulin resistance in nondiabetic Greek women. Eur J Endocrinol 161: 845-852.
37. Maeda K, Okubo K, Shimomura I, Funahashi T, Matsuzawa Y, et al. (1996) cDNA cloning and expression of a novel adipose specific collagen-like factor, apM1 (AdiPoseMost abundant Gene transcript 1). Biochem Biophys Res Commun 221: 286-289.
38. Arita Y, Kihara S, Ouchi N, Takahashi M, Maeda K, et al. (1999) Paradoxical decrease of an adipose-specific protein, adiponectin, in obesity. Biochem Biophys Res Commun 257: 79-83.
39. Daimon M, Oizumi T, Kato T, (2012) Decreased serum levels of adiponectin as a risk for development of type 2 diabetes, and impaired glucose tolerance as a risk for stroke-the Funagata study. Nihon Rinsho 70: 256-259.
40. Yamauchi T, Kamon J, Waki H, Terauchi Y, Kubota N, et al. (2001) The fat-derived hormone adiponectin reverses insulin resistance associated with both lipoatrophyand obesity. Nat Med 7: 941-946.
41. Chen MW, Ye S, Zhao LL, Wang SY, Li YX, et al. (2012) Association of plasma total and high-molecular-weight adiponectin with risk of colorectal cancer: an observational study in Chinese male. Med Oncol 29: 3129-3135.
42. Otake S, Takeda H, Fujishima S, Fukui T, Orii T, et al. (2010) Decreased levels of plasma adiponectin associated with increased risk ofcolorectal cancer. World J Gastroenterol 16: 1252-1257.
43. Kim AY, Lee YS, Kim KH, Lee JH, Lee HK, et al. (2010) Adiponectin represses colon cancer cell proliferation via AdipoR1- and-R2-mediated AMPK activation. Mol Endocrinol 24: 1441-1452.
44. Sugiyama M, Takahashi H, Hosono K, Endo H, Kato S, et al. (2009) ADIPOQ inhibits colorectal cancer cell growth through the AMPK/mTOR pathway. Int J Oncol 34: 339-344.
45. Wang Y, Lam KS, Xu JY, Lu G, Xu LY, et al. (2005) Adiponectin inhibits cell proliferation by interacting with several growth factors in anoligomerization-dependent manner. J Biol Chem 280: 18341-18347.
46. Park M, Youn B, Zheng XL, Wu D, Xu A, et al. (2011) Globular adiponectin, acting via AdipoR1/APPL1, protects H9c2 cells from hypoxia/reoxygenation-induced apoptosis. PLoS One 6: e19143.
47. Saxena A, Chumanevich A, Fletcher E, Larsen B, Lattwein K, et al. (2012) Adiponectin deficiency: Role in chronic inflammation induced colon cancer. Biochim Biophys Acta 1822: 527-536.
48. Schechter S, (1995) Inflammatory bowel disease and its association with colorectal cancer. R I Med 78: 161-163.
49. Kaklamani VG, Wisinski KB, Sadim M, Gulden C, Do A, et al. (2008) Variants of the adiponectin (ADIPOQ) and adiponectin receptor 1 (ADIPOR1) genesand colorectal cancer risk. JAMA 300: 1523-1531.
50. He B, Pan Y, Zhang Y, Bao Q, Chen L, et al. (2011) Effects of genetic variations in the adiponectin pathway genes on the risk of colorectal cancer in the Chinese population. BMC Med Genet 12: 94.
51. Partida-Pérez M, de la Luz Ayala-Madrigal M, Peregrina-Sandoval J, Macías-Gómez N, Moreno-Ortiz J, et al. (2010) Association of LEP and ADIPOQ common variants with colorectal cancer in Mexican patients. Cancer Biomark 7: 117-121.
52. Al-Harithy RN, Al-Zahrani MH, (2012) The adiponectin gene, ADIPOQ, and genetic susceptibility to colon cancer. Oncol Lett 3: 176-180.
53. Albala BC, Jiménez RB, Pérez BF, Liberman GC, (2006) Fatty acid binding protein 2 (FABP-2) polymorphism, obesity and insulin resistance. Rev Med Chil 134: 372-379.
54. von Eynatten M, Hamann A, Twardella D, Nawroth PP, Brenner H, et al. (2006) Relationship of adiponectin with markers of systemic inflammation, atherogenic dyslipidemia, and heart failure in patients with coronary heart disease. Clin Chem 52: 853-859.
55. Chamberlain AM, Schreiner PJ, Fornage M, Loria CM, Siscovick D, et al. (2009) Ala54Thr polymorphism of the fatty acid binding protein 2 gene and saturated fat intake in relation to lipid levels and insulin resistance: the Coronary Artery Risk Development in Young Adults (CARDIA) study. Metabolism 58: 1222-1228.
56. Weiss EP, Brown MD, Shuldiner AR, Hagberg JM, (2002) Fatty acid binding protein-2 gene variants and insulin resistance: gene and gene-environment interaction effects. Physiol Genomics 10: 145-157.
57. Azzu V, Jastroch M, Divakaruni AS, Brand MD, (2010) The regulation and turnover of mitochondrial uncoupling proteins. Biochim Biophys Acta 1797: 785-791.
58. Ochoa MC, Santos JL, Azcona C, Moreno-Aliaga MJ, Martínez-González MA, et al. (2007) Association between obesity and insulin resistance with UCP2-UCP3 gene variants in Spanish children and adolescents. Mol Genet Metab 92: 351-358.
59. D'Adamo M, Perego L, Cardellini M, Marini MA, Frontoni S, et al. (2004) The-866A/A genotype in the promoter of the human uncoupling protein 2 gene is associated withinsulin resistance and increased risk of type 2 diabetes. Diabetes 53: 1905-1910.
60. Chaolu H, Asakawa A, Ushikai M, Li YX, Cheng KC, et al. (2011) Effect of exercise and high-fat diet on plasma adiponectin and nesfatin levels in mice. Exp Ther Med 2: 369-373.
61. Simcox JA, McClain DA, (2013) Iron and diabetes risk. Cell Metab 17: 329-341.
62. Tang FY, Pai MH, Chiang EP, (2012) Consumption of high-fat diet induces tumor progression and epithelial-mesenchymal transition of colorectal cancer in a mouse xenograft model. J Nutr Biochem 23: 1302-1313.
63. Knize MG, Salmon CP, Pais P, Felton JS, (1999) Food heating and the formation of heterocyclic aromatic amine and polycyclic aromatichydrocarbon mutagens/carcinogens. Adv Exp Med Biol 459: 179-193.